A study published in JACC suggests that, when combined with high-intensity statin therapy, evolocumab can be an effective tool for lowering LDL-cholesterol in patients who have experienced an acute coronary syndrome.

The FDA is testing metformin, a popular drug used to treat type 2 diabetes, for carcinogenic impurities.

Beta-blocker use was linked to an increased risk of heart failure hospitalizations in a recent study of patients with “stiff heart” HF—a concerning finding considering the majority of such patients take the drugs as part of their care regimen.

A nine-week mindfulness training course helped hypertensive patients lower their blood pressure and improve healthy habits in a study out of the Mindfulness Center at Brown University’s School of Public Health.

Novoheart, a Vancouver-based stem cell biotech company, is pairing with biopharmaceutical giant AstraZeneca to develop the world’s first human-specific in vitro functional model of heart failure with preserved ejection fraction.

Brushing teeth three or more times a day could dramatically lower a person’s risk for CVDs like heart failure and atrial fibrillation, according to preliminary research out of Ewha Womans University in Seoul, South Korea.

Abbott’s transcatheter tricuspid valve repair system is a safe and effective approach to treating tricuspid regurgitation in heart patients with few other options, according to data published in The Lancet.

Surgical candidates with active cannabis use disorders were nearly twice as likely as their non-user peers to suffer a heart attack after surgery, according to research published in Anesthesiology on Nov. 25.